LGALS3 and glioblastoma: However, the aim of this study, a detection for diagnosis and/or prognosis marker candidates for GBM, namely, CD276, GATA3, and LGALS3, would have been achieved successfully by using of their expression data, clinical information, and multivariable analyses.